High Tech Pharm Co., Ltd. (KOSDAQ:106190)

High Tech Pharm Revenue

In the year 2025, High Tech Pharm had annual revenue of 70.18B KRW, down -9.46%. High Tech Pharm had revenue of 14.04B in the quarter ending December 31, 2025, a decrease of -27.84%.

• Revenue: 70.18B
• Revenue Growth: -9.46%
• P/S Ratio: 2.40
• Revenue / Employee: 1.08B
• Employees: n/a
• Market Cap: 168.11B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	70.18B	-7.33B	-9.46%
Dec 31, 2024	77.51B	740.98M	0.97%
Dec 31, 2023	76.77B	-26.18B	-25.43%
Dec 31, 2022	102.95B	29.66B	40.47%
Dec 31, 2021	73.29B	-1.17B	-1.58%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 21, 2026

Data Sources Report a data error